Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Incyte Corporation

02 1MorphoSys

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Tafasitamab

Brand Name : Minjuvi

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 200mg

Packaging :

Approval Date : 26/08/2021

Application Number : 20200504000115

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Tafasitamabum

Brand Name : Minjuvi

Dosage Form : Injectable Solution

Dosage Strength : 200mg

Packaging :

Approval Date : 22/03/2022

Application Number : 68083

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

TAFASITAMAB

Brand Name : MINJUVI

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 200MG/VIAL

Packaging :

Approval Date :

Application Number : 2518627

Regulatory Info : Schedule D

Registration Country : Canada

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Tafasitamab

Brand Name : Minjuvi

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 200MG

Packaging :

Approval Date : 2021-09-28

Application Number : 1211570001

Regulatory Info : Authorized

Registration Country : Spain

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

TAFASITAMAB-CXIX

Brand Name : MONJUVI

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 12MG/KG

Packaging :

Approval Date :

Application Number : 761163

Regulatory Info :

Registration Country : USA

blank